$AMRX
Amneal Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations
AMRX chart
What traders are saying about $AMRX
Latest postsAmneal Pharmaceuticals, Inc. news
- Amneal Pharmaceuticals stock hits a USD 21.46 52-week high
ad-hoc-news.de ·
- Amneal Pharmaceuticals $240M Expansion in Piscataway, NJ
Hoodline ·
- Amneal Pharmaceuticals expands New Jersey presence as stock edges higher
Traders Union ·
- NJEDA approves manufacturing award to boost Amneal Pharmaceuticals investment in state
ROI-NJ ·
- Amneal Pharmaceuticals stock hits 52-week high at $21.18
Investing.com ·
- Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
Yahoo Finance ·
- Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
- Implied Volatility Surging for Amneal Pharmaceuticals Stock Options
Yahoo Finance ·
- What Amneal Pharmaceuticals Stock's Upcoming Earnings Means For Shareholders
Simply Wall Street ·
- NJEDA Award Supports Amneal Pharmaceuticals’ $240M Expansion in NJ
New Jersey Business & Industry Association ·
- Amneal Pharmaceuticals, Inc. (AMRX) stock price, news, quote and history
Yahoo Finance Singapore ·
- Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
Yahoo Finance ·
Amneal Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.02B | $2.79B | $2.39B | $2.21B |
| Net income | $72.1M | -$116.9M | -$84.0M | -$270.6M |
| Diluted EPS | $0.22 | $-0.38 | $-0.48 | $-0.86 |
| Total assets (year end) | $3.68B | $3.50B | $3.47B | $3.80B |
| Cash and equivalents (year end) | $282.0M | $110.6M | $91.5M | $26.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amneal Pharmaceuticals, Inc.
- Ticker
- AMRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Fiscal year end
- December 31
- SEC CIK
- 1723128
- Former names
- Atlas Holdings, Inc.
Frequently asked questions
What exchange is Amneal Pharmaceuticals, Inc. listed on?
Amneal Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AMRX.
What industry is Amneal Pharmaceuticals, Inc. in?
Amneal Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
When does Amneal Pharmaceuticals, Inc.'s fiscal year end?
Amneal Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Amneal Pharmaceuticals, Inc. report?
Amneal Pharmaceuticals, Inc. reported $3.02B in revenue for calendar year 2025, according to its SEC filings.